Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and Schizophrenia
by Harald Murck, MD, PhD; Thomas Laughren, MD; Femke Lamers,
April 20, 2015
No Comments
by Harald Murck, MD, PhD; Thomas Laughren, MD; Femke Lamers,
by Radhika Bawa, MD, and Jonathan R. Scarff, MD Dr.
by Jae Lee, DO; Puneet Narang, MD; Manasa Enja, MD;
by Randy A. Sansone, MD, and Lori A. Sansone, MD
Innov Clin Neurosci. 2015;12(1–2):10–11.
by Richard G. Cockerill; Bridget K. Biggs, PhD; Tyler S.
by ISCTM Suicidal Ideation and Behavior Assessment Workgroup: Phillip B.
by John H. Greist, MD; James C. Mundt, PhD; Chad
by David V. Sheehan, MD, MBA; Larry D. Alphs, MD,
Site Design by: Dynamic Wave Consulting